In the BioHarmony Drug Report Database
Ambenonium
Mytelase (ambenonium) is a small molecule pharmaceutical. Ambenonium was first approved as Mytelase on 1982-01-01. It is used to treat myasthenia gravis in the USA.
Trade Name
|
Mytelase |
|---|---|
Common Name
|
ambenonium |
ChEMBL ID
|
CHEMBL1652 |
Indication
|
myasthenia gravis |
Drug Class
|
Quaternary ammonium derivatives |
Image (chem structure or protein)